Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) - Net Assets
Based on the latest financial reports, Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) has net assets worth CN¥13.76 Billion CNY (≈ $2.01 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥16.89 Billion ≈ $2.47 Billion USD) and total liabilities (CN¥3.13 Billion ≈ $457.33 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Jiangsu Yuyue Medical Equipment & Supply tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥13.76 Billion |
| % of Total Assets | 81.5% |
| Annual Growth Rate | 25.43% |
| 5-Year Change | 58.43% |
| 10-Year Change | 170.62% |
| Growth Volatility | 48.42 |
Jiangsu Yuyue Medical Equipment & Supply Co Ltd - Net Assets Trend (2005–2025)
This chart illustrates how Jiangsu Yuyue Medical Equipment & Supply Co Ltd's net assets have evolved over time, based on quarterly financial data. See how many days can Jiangsu Yuyue Medical Equipment & Supply fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Jiangsu Yuyue Medical Equipment & Supply Co Ltd (2005–2025)
The table below shows the annual net assets of Jiangsu Yuyue Medical Equipment & Supply Co Ltd from 2005 to 2025. For live valuation and market cap data, see Jiangsu Yuyue Medical Equipment & Supply (002223) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥13.36 Billion ≈ $1.95 Billion |
+5.54% |
| 2024-12-31 | CN¥12.65 Billion ≈ $1.85 Billion |
+6.20% |
| 2023-12-31 | CN¥11.92 Billion ≈ $1.74 Billion |
+18.37% |
| 2022-12-31 | CN¥10.07 Billion ≈ $1.47 Billion |
+19.42% |
| 2021-12-31 | CN¥8.43 Billion ≈ $1.23 Billion |
+12.47% |
| 2020-12-31 | CN¥7.49 Billion ≈ $1.10 Billion |
+21.74% |
| 2019-12-31 | CN¥6.16 Billion ≈ $900.88 Million |
+11.03% |
| 2018-12-31 | CN¥5.54 Billion ≈ $811.36 Million |
-0.47% |
| 2017-12-31 | CN¥5.57 Billion ≈ $815.20 Million |
+12.88% |
| 2016-12-31 | CN¥4.94 Billion ≈ $722.16 Million |
+131.45% |
| 2015-12-31 | CN¥2.13 Billion ≈ $312.01 Million |
+21.04% |
| 2014-12-31 | CN¥1.76 Billion ≈ $257.78 Million |
+16.13% |
| 2013-12-31 | CN¥1.52 Billion ≈ $221.97 Million |
+15.66% |
| 2012-12-31 | CN¥1.31 Billion ≈ $191.91 Million |
+18.44% |
| 2011-12-31 | CN¥1.11 Billion ≈ $162.04 Million |
+25.91% |
| 2010-12-31 | CN¥879.47 Million ≈ $128.69 Million |
+82.27% |
| 2009-12-31 | CN¥482.51 Million ≈ $70.61 Million |
+18.94% |
| 2008-12-31 | CN¥405.69 Million ≈ $59.36 Million |
+196.10% |
| 2007-12-31 | CN¥137.01 Million ≈ $20.05 Million |
-11.14% |
| 2006-12-31 | CN¥154.18 Million ≈ $22.56 Million |
+7.32% |
| 2005-12-31 | CN¥143.67 Million ≈ $21.02 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Jiangsu Yuyue Medical Equipment & Supply Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 16955.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥9.70 Billion | 73.22% |
| Other Components | CN¥3.55 Billion | 26.78% |
| Total Equity | CN¥13.24 Billion | 100.00% |
Jiangsu Yuyue Medical Equipment & Supply Co Ltd Competitors by Market Cap
The table below lists competitors of Jiangsu Yuyue Medical Equipment & Supply Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
|
$3.83 Billion |
|
Banco del Bajío S.A. Institución de Banca Múltiple
MX:BBAJIOO
|
$3.83 Billion |
|
First BanCorp.
NYSE:FBP
|
$3.83 Billion |
|
Thinkon Semiconductor Jinzhou Corp
SHG:688233
|
$3.83 Billion |
|
USA Compression Partners LP
NYSE:USAC
|
$3.83 Billion |
|
Ventia Services Group Ltd
AU:VNT
|
$3.82 Billion |
|
Iskenderun Demir ve Celik AS
IS:ISDMR
|
$3.82 Billion |
|
Global Health Limited
NSE:MEDANTA
|
$3.81 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Jiangsu Yuyue Medical Equipment & Supply Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 12,535,332,607 to 13,240,967,252, a change of 705,634,645 (5.6%).
- Net income of 1,481,794,880 contributed positively to equity growth.
- Dividend payments of 799,010,395 reduced retained earnings.
- Other comprehensive income decreased equity by 827,995,965.
- Other factors increased equity by 850,846,125.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥1.48 Billion | +11.19% |
| Dividends Paid | CN¥799.01 Million | -6.03% |
| Other Comprehensive Income | CN¥-828.00 Million | -6.25% |
| Other Changes | CN¥850.85 Million | +6.43% |
| Total Change | CN¥- | 5.63% |
Book Value vs Market Value Analysis
This analysis compares Jiangsu Yuyue Medical Equipment & Supply Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.98x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 231.77x to 1.98x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | CN¥0.11 | CN¥26.09 | x |
| 2006-12-31 | CN¥0.14 | CN¥26.09 | x |
| 2007-12-31 | CN¥0.24 | CN¥26.09 | x |
| 2008-12-31 | CN¥0.51 | CN¥26.09 | x |
| 2009-12-31 | CN¥0.57 | CN¥26.09 | x |
| 2010-12-31 | CN¥1.01 | CN¥26.09 | x |
| 2011-12-31 | CN¥1.62 | CN¥26.09 | x |
| 2012-12-31 | CN¥1.49 | CN¥26.09 | x |
| 2013-12-31 | CN¥1.73 | CN¥26.09 | x |
| 2014-12-31 | CN¥2.00 | CN¥26.09 | x |
| 2015-12-31 | CN¥2.40 | CN¥26.09 | x |
| 2016-12-31 | CN¥5.21 | CN¥26.09 | x |
| 2017-12-31 | CN¥5.22 | CN¥26.09 | x |
| 2018-12-31 | CN¥5.49 | CN¥26.09 | x |
| 2019-12-31 | CN¥6.06 | CN¥26.09 | x |
| 2020-12-31 | CN¥7.42 | CN¥26.09 | x |
| 2021-12-31 | CN¥8.31 | CN¥26.09 | x |
| 2022-12-31 | CN¥9.95 | CN¥26.09 | x |
| 2023-12-31 | CN¥11.83 | CN¥26.09 | x |
| 2024-12-31 | CN¥12.57 | CN¥26.09 | x |
| 2025-12-31 | CN¥13.21 | CN¥26.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Jiangsu Yuyue Medical Equipment & Supply Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.19%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.63%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 1.21x
- Recent ROE (11.19%) is below the historical average (18.94%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 52.00% | 27.65% | 0.66x | 2.83x | CN¥47.47 Million |
| 2006 | 21.86% | 13.60% | 0.59x | 2.73x | CN¥17.12 Million |
| 2007 | 27.56% | 13.08% | 1.07x | 1.97x | CN¥24.13 Million |
| 2008 | 15.23% | 15.41% | 0.89x | 1.11x | CN¥21.24 Million |
| 2009 | 21.14% | 18.69% | 0.84x | 1.34x | CN¥52.99 Million |
| 2010 | 18.45% | 18.20% | 0.83x | 1.22x | CN¥73.69 Million |
| 2011 | 20.61% | 19.48% | 0.90x | 1.18x | CN¥116.58 Million |
| 2012 | 18.76% | 18.60% | 0.85x | 1.18x | CN¥113.95 Million |
| 2013 | 17.13% | 18.12% | 0.79x | 1.20x | CN¥107.41 Million |
| 2014 | 16.97% | 17.66% | 0.79x | 1.22x | CN¥121.98 Million |
| 2015 | 17.22% | 17.32% | 0.72x | 1.38x | CN¥152.76 Million |
| 2016 | 10.17% | 18.93% | 0.45x | 1.18x | CN¥8.47 Million |
| 2017 | 11.30% | 16.72% | 0.53x | 1.26x | CN¥67.93 Million |
| 2018 | 13.30% | 17.38% | 0.61x | 1.26x | CN¥180.34 Million |
| 2019 | 12.40% | 16.23% | 0.58x | 1.31x | CN¥145.51 Million |
| 2020 | 23.65% | 26.15% | 0.67x | 1.36x | CN¥1.02 Billion |
| 2021 | 17.92% | 21.50% | 0.57x | 1.45x | CN¥655.21 Million |
| 2022 | 16.18% | 22.46% | 0.47x | 1.53x | CN¥609.04 Million |
| 2023 | 20.37% | 30.05% | 0.50x | 1.36x | CN¥1.22 Billion |
| 2024 | 14.40% | 23.87% | 0.48x | 1.25x | CN¥552.17 Million |
| 2025 | 11.19% | 18.63% | 0.49x | 1.21x | CN¥157.70 Million |
Industry Comparison
This section compares Jiangsu Yuyue Medical Equipment & Supply Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,839,020,898
- Average return on equity (ROE) among peers: 16.32%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | CN¥13.76 Billion | 52.00% | 0.23x | $3.83 Billion |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $146.21 Million | 21.81% | 0.54x | $358.26 Million |
| Double Medical Technology Inc (002901) | $580.13 Million | 37.81% | 0.24x | $2.55 Billion |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $2.85 Billion | 49.59% | 0.20x | $483.16 Million |
| Lepu Medical Tech Beijing (300003) | $8.00 Billion | 21.55% | 0.99x | $3.24 Billion |
| INKON Life Technology Co Ltd (300143) | $1.37 Billion | -51.44% | 0.43x | $752.32 Million |
| Edan Instruments Inc (300206) | $1.73 Billion | 13.36% | 0.18x | $1.06 Billion |
| Guangdong Biolight Meditech Co Ltd (300246) | $427.94 Million | 7.90% | 0.21x | $604.04 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.43 Billion | 5.13% | 0.23x | $451.37 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $1.15 Billion |
About Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. provides medical devices and health product in China and internationally. It offers respiratory solutions, including PAP therapy, oxygen concentrators, nebulizers, high flow oxygen therapy, and airway clearances; diabetes management solutions; medical diagnostic devices, such as blood pressure monitors, oximeters, and thermometers; wheelchairs; A… Read more